U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 191 - 200 of 417 results

Status:
Other

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Other

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Other

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Other

Class (Stereo):
CHEMICAL (ABSOLUTE)

5-Methylthioadenosine (MTA) is a naturally occurring sulfur-containing nucleoside present in all mammalian tissues. The major source of MTA in cells is formed from S-adenosylmethionine during the synthesis of the polyamines spermine and spermidine. In most cells MTA does not accumulate is significant amounts and is rapidly metabolized by 5-methythioadenosine phosphorylase (MTAP) to yield adenine (Ade) and 5-methylthioribose-1-phosphate (MTR1P). The removal of accumulating MTA by MTAP is necessary for the cell to carry out polyamine metabolism, since MTA is a strong inhibitor of spermine synthase. Intracellular fluctuations in MTA levels could participate in the regulation of the liver proliferative response, and administration of MTA have hepatorptective effect in a model of CCl4-induced chronic liver damage.

Showing 191 - 200 of 417 results